SC 13D Filing

Company

Dianthus Therapeutics, Inc. /DE/

Filed

January 31, 2024

Accession Number

0000919574-24-000598

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →